DE2033852A1 - Verfahren zur Herstellung neuer heterocychscher Verbindungen - Google Patents

Verfahren zur Herstellung neuer heterocychscher Verbindungen

Info

Publication number
DE2033852A1
DE2033852A1 DE19702033852 DE2033852A DE2033852A1 DE 2033852 A1 DE2033852 A1 DE 2033852A1 DE 19702033852 DE19702033852 DE 19702033852 DE 2033852 A DE2033852 A DE 2033852A DE 2033852 A1 DE2033852 A1 DE 2033852A1
Authority
DE
Germany
Prior art keywords
formula
compounds
above meaning
group
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702033852
Other languages
German (de)
English (en)
Inventor
Anton Dr Ariesheim Rissi Erwin Dr Basel Ebnother, (Schweiz)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CH1040369A priority Critical patent/CH511886A/de
Priority to CH1040269A priority patent/CH511885A/de
Priority to CH1814869A priority patent/CH518973A/de
Priority to GB1321692D priority patent/GB1321692A/en
Priority to GB1321691D priority patent/GB1321691A/en
Priority to NL7009431A priority patent/NL7009431A/xx
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to DE19702033852 priority patent/DE2033852A1/de
Priority to FR7024950A priority patent/FR2059492B1/fr
Priority to CA087,327A priority patent/CA955259A/en
Priority to BE753068D priority patent/BE753068A/xx
Priority to AT241472A priority patent/AT317882B/de
Priority to OA53973A priority patent/OA03576A/xx
Priority to AT614570A priority patent/AT312586B/de
Priority to AT241572A priority patent/AT317883B/de
Publication of DE2033852A1 publication Critical patent/DE2033852A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19702033852 1969-07-08 1970-07-01 Verfahren zur Herstellung neuer heterocychscher Verbindungen Pending DE2033852A1 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
CH1040369A CH511886A (de) 1969-07-08 1969-07-08 Verfahren zur Herstellung neuer Furanonderivate
CH1040269A CH511885A (de) 1969-07-08 1969-07-08 Verfahren zur Herstellung neuer Furanonderivate
CH1814869A CH518973A (de) 1969-07-08 1969-12-05 Verfahren zur Herstellung neuer Furanonderivate
GB1321692D GB1321692A (en) 1969-07-08 1970-06-16 Dihydro-3-piperidyl-2 3h-furanone derivatives
GB1321691D GB1321691A (en) 1969-07-08 1970-06-16 Dihydro-3-piperidyl-2 3h-furanone derivatives
NL7009431A NL7009431A (xx) 1969-07-08 1970-06-26
DE19702033852 DE2033852A1 (de) 1969-07-08 1970-07-01 Verfahren zur Herstellung neuer heterocychscher Verbindungen
FR7024950A FR2059492B1 (xx) 1969-07-08 1970-07-06
CA087,327A CA955259A (en) 1969-07-08 1970-07-06 Dihydro-3-(4-hydroxy-4-piperidyl-1-phenethyl)-2(3h) furanone derivatives
BE753068D BE753068A (fr) 1969-07-08 1970-07-06 Nouveaux derives de la furanone, leur preparation et medicaments contenant ces derives
AT241472A AT317882B (de) 1969-07-08 1970-07-07 Verfahren zur Herstellung von neuen Tetrahydrofuranderivaten und ihren Säureadditionssalzen
OA53973A OA03576A (fr) 1969-07-08 1970-07-07 Nouveaux dérivés de la furanone et leur préparation.
AT614570A AT312586B (de) 1969-07-08 1970-07-07 Verfahren zur Herstellung von neuen Tetrahydrofuranderivaten und ihren Säureadditionssalzen
AT241572A AT317883B (de) 1969-07-08 1970-07-07 Verfahren zur Herstellung von neuen Tetrahydrofuranderivaten und ihren Säureadditionssalzen

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
CH1040369A CH511886A (de) 1969-07-08 1969-07-08 Verfahren zur Herstellung neuer Furanonderivate
CH1040269A CH511885A (de) 1969-07-08 1969-07-08 Verfahren zur Herstellung neuer Furanonderivate
CH1184369 1969-08-05
CH1681169 1969-11-12
CH1814869A CH518973A (de) 1969-07-08 1969-12-05 Verfahren zur Herstellung neuer Furanonderivate
CH319970 1970-03-05
CH589570 1970-04-21
CH589370 1970-04-21
GB2923370 1970-06-16
GB6001872 1970-06-16
NL7009431A NL7009431A (xx) 1969-07-08 1970-06-26
DE19702033852 DE2033852A1 (de) 1969-07-08 1970-07-01 Verfahren zur Herstellung neuer heterocychscher Verbindungen
FR7024950A FR2059492B1 (xx) 1969-07-08 1970-07-06

Publications (1)

Publication Number Publication Date
DE2033852A1 true DE2033852A1 (de) 1971-01-14

Family

ID=27583939

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702033852 Pending DE2033852A1 (de) 1969-07-08 1970-07-01 Verfahren zur Herstellung neuer heterocychscher Verbindungen

Country Status (7)

Country Link
AT (3) AT317882B (xx)
BE (1) BE753068A (xx)
CH (3) CH511886A (xx)
DE (1) DE2033852A1 (xx)
FR (1) FR2059492B1 (xx)
GB (2) GB1321692A (xx)
NL (1) NL7009431A (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085724A1 (en) * 1970-03-20 1971-12-31 Sandoz Sa Analgesic basic furanone derivs

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH530387A (de) * 1970-07-29 1972-11-15 Sandoz Ag Verfahren zur Herstellung neuer Furano-Derivate
US4381890A (en) * 1980-05-19 1983-05-03 Wallace George A Incident light filter for cameras

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH497458A (de) * 1967-04-19 1970-10-15 Sandoz Ag Verfahren zur Herstellung neuer Phenothiazin-Derivate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085724A1 (en) * 1970-03-20 1971-12-31 Sandoz Sa Analgesic basic furanone derivs

Also Published As

Publication number Publication date
FR2059492A1 (xx) 1971-06-04
AT312586B (de) 1974-01-10
GB1321691A (en) 1973-06-27
AT317882B (de) 1974-09-25
FR2059492B1 (xx) 1974-06-14
NL7009431A (xx) 1971-01-12
CH518973A (de) 1972-02-15
BE753068A (fr) 1971-01-06
AT317883B (de) 1974-09-25
CH511885A (de) 1971-08-31
CH511886A (de) 1971-08-31
GB1321692A (en) 1973-06-27

Similar Documents

Publication Publication Date Title
DE2614406C2 (xx)
EP0287907B1 (de) Pyrazolo[3,4-d]pyrimidine, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel
CH664567A5 (de) Aromatische carbonsaeure- und sulfonsaeureester oder -amide.
DE4102103A1 (de) Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0000395B1 (de) 2-Piperazinotetraline, ihre Herstellung und Verwendung als Arzneimittel
CH617694A5 (xx)
DE2719294A1 (de) Neue derivate des 1,4-benzodioxans, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE2033852A1 (de) Verfahren zur Herstellung neuer heterocychscher Verbindungen
EP0233483B1 (de) Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung
DE3424586A1 (de) 3-aminocarbonylmethoxy-5-phenyl-pyrazol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2238839A1 (de) Neue morphinon-derivate, deren saeureadditionssalze, verfahren zu ihrer herstellung sowie ihre verwendung zur herstellung von arzneimitteln
EP0037990B1 (de) Phenyl-chinolizidine, entsprechende pharmazeutische Präparate, die Herstellung der Wirkstoffe sowie entsprechende Ausgangsverbindungen
DE3721222A1 (de) Glycinderivate
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
AT390952B (de) Verfahren zur herstellung von neuen furan- oder thiophenderivaten
DE2241027A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
Remy et al. A comparison of the antiserotonin, antihistamine, and anticholinergic activity of cyproheptadine with analogs having furan nuclei fused to the 10, 11-vinylene bridge
DE2734270C2 (xx)
DE2318273B2 (de) Basisch substituierte 13-Benzodioxolderivate und deren pharmakologisch verträgliche Salze sowie diese Verbindungen enthaltende Arzneimittel
DE2229770A1 (de) N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
CH646170A5 (de) Pyrazolo(1,5-c)chinazolinderivate und diese enthaltende arzneimittel.
DE2707658A1 (de) Neue iminoverbindungen und verfahren zu ihrer herstellung
CH641800A5 (de) Pyrido-pyrimidine, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittel.
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten